Category Archives: Uncategorized

$39 million settlement over Target data breach

NBC News reported last week: Target Corp. has agreed to pay $39.4 million to resolve claims by banks and credit unions that said they lost money because of the retailer's late 2013 data breach. The preliminary settlement filed on Wednesday resolves class-action claims by lenders seeking to hold Target responsible for their costs to reimburse […]

Net neutrality was back in court Friday

NPR discusses what's at stake in the latest court battle over net neutrality, in which the D.C. Circuit heard argument Friday. Last Feburary, the FCC redefined its role in regulating the internet; this lawsuit is the telecom companies' challenge to the FCC's action. For our discussion of the last D.C. Circuit decision on net neutrality, go here.

California Supreme Court: State-law suit alleging food is mislabled as “organic” is not federally preempted

The decision in Quesada v. Herb Thyme Farms is here. Here's a brief excerpt from the beginning of the opinion that sets the scene and summarizes the holding: To buyers and sellers alike "labels matter." (Kwikset Corp. v. Superior Court (2011) 51 Cal.4th 310, 328.) They serve as markers for a host of tangible and […]

A new Obamacare myth is born: Hordes of Americans are ‘gaming’ the system

That's the name of this article by veteran LA Times columnist Michael Hiltzik. Here's how it starts: With the traditional attack points on the Affordable Care Act having faded away–most enrollees were already insured (wrong), millions of people lost their coverage and couldn't replace it (wrong), etc.–Obamacare's critics have been looking for new ones. An […]

Former Massey CEO guilty of conspiracy, acquitted of other charges

Earlier this fall, we flagged the federal criminal trial of Massey Energy's former CEO Don Blankenship as an important test of corporate accountability. Blankenship was accused of skimping on mine worker safety and thereby contributing to the 29 deaths that occurred in the 2010 explosion of the Upper Big Branch mine. Yesterday, a jury found […]

“How an $84,000 drug got its price”

…in this week's Post, is the story of a drugmaker choosing profits over accessibility in pricing a Hepatitis C drug. "Gilead Sciences executives were acutely aware in 2013 that their plan to charge an exorbitantly high price for a powerful new hepatitis C drug would spark public outrage, but they pursued the profit-driven strategy anyway," […]

CFPB finds CARD Act helped consumers avoid $16 Billion in credit-card fees

A report from the Consumer Financial Protection Bureau released yesterday details how the Credit Card Accountability Responsibility and Disclosure Act (CARD Act) has helped reduce the cost of “gotcha” credit card fees by more than $16 billion. "Since the reform law, total costs to consumers have fallen with the elimination of certain back-end pricing practices […]